Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2021-03-12 | Albert Bourla, DVM, Ph.D. AGE:59 Chairman and Chief Executive Officer DIRECTOR SINCE: 2018 Chairman of the Board of Pfizer since January 2020; Chief Executive Officer of Pfizer since January 2019; Chief Operating Officer of Pfizer from January 2018 until December 2018; Group President, Pfizer Innovative Health from June 2016 until December 2017; Group President, Global Innovative Pharma Business of Pfizer from February 2016 until June 2016 (responsible for Vaccines, Oncology and Consumer Healthcare since 2014). President and General Manager of Established Products Business Unit of Pfizer from 2010 until 2013. Since joining Pfizer in 1993, Dr. Bourla has served in various leadership positions with increasing responsibility within Pfizer’s former Animal Health and global commercial organizations. Board member of Pharmaceutical Research and Manufacturers of America (PhRMA). Board member of The Pfizer Foundation, which promotes access to quality healthcare. Member of the Board of the Partnership for New York City and Catalyst. KEY SKILLS & EXPERIENCE: Business Leadership & Operations/Human Capital Management/International Business/Healthcare & Pharma: Dr. Bourla has over 25 years of leadership experience and a demonstrated track record for delivering strong business results. Dr. Bourla has deep knowledge of the healthcare industry as he has held a number of senior global positions across a range of businesses in five different countries (including eight different cities) over the course of his career, which enables him to provide important insights and perspectives to our Board on the company’s commercial, strategic, manufacturing and global product development functions. As Chairman and CEO, Dr. Bourla provides an essential link between management and the Board regarding management’s business perspectives. In addition, his experiences on the Board of PhRMA enable him to bring a broad perspective on issues facing our industry to the Board. Medicine & Science: Dr. Bourla brings expertise in medicine and science to the Board as he is a Doctor of Veterinary Medicine and holds a Ph.D. in the Biotechnology of Reproduction from the Veterinary School of Aristotle University. |
| 2022-03-17 | Director Nominees: Albert Bourla, DVM, Ph.D. - Business Leadership & Operations. |
| 2023-03-16 | Albert Bourla, DVM, Ph.D., Chairman and CEO, Age: 61, Director Since: 2018, Total Compensation: $33,017,453 |
| 2024-03-14 | Albert Bourla, DVM, Ph.D. Chairman and CEO Age: 62 Director Since: 2018 Dr. Bourla does not receive any compensation for his service as a Director. |
| 2025-03-13 | Albert Bourla, DVM, Ph.D. Chairman and CEO Age: 63 Director Since: 2018 2024 Director Compensation Table: Dr. Bourla does not receive any compensation for his service as a Director. Summary Compensation Table Total: 24,648,727 |
Data sourced from SEC filings. Last updated: 2025-07-01